ANTIBODY DRUG CONJUGATES AND METHODS FOR MAKING THEREOF
This application discloses microorganisms and methods of producing GNAQ/GNA11 inhibitors and methods of making antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The disclosure also relates to formulations comprising antibody drug co...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This application discloses microorganisms and methods of producing GNAQ/GNA11 inhibitors and methods of making antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor. The disclosure also relates to formulations comprising antibody drug conjugates of anti-PMEL17 antibodies or antigen binding fragments conjugated to a GNAQ/GNA11 inhibitor and methods of treating or preventing cancer using the formulations.
Esta solicitud desvela microorganismos y métodos de producción de inhibidores de GNAQ/GNA11 y métodos de fabricación de conjugados anticuerpo-fármaco de anticuerpos anti-PMEL17 o fragmentos de unión a antígeno conjugados con un inhibidor de GNAQ/GNA11. La divulgación también se refiere a formulaciones que comprenden conjugados anticuerpo-fármaco de anticuerpos anti-PMEL17 o fragmentos de unión a antígeno conjugados con un inhibidor de GNAQ/GNA11 y métodos de tratamiento o prevención del cáncer usando las formulaciones. |
---|